Proactive P4 medicine making blood a window into health and disease

Perspectives for effective cancer drug development: The EORTC SPECTA Initiative

microRNA replacement in malignant pleural mesothelioma

EORTC fosters move towards tailored cancer treatment through the SPECTA initiative in colorectal cancer

Novel drug targets and potential combinations in childhood brain tumours

ecancermedicalscience editor's choice for June 2014

Retinoic acid in acute promyelocytic leukaemia as alternative to chemotherapy

Gdf -11 a new target to improve anaemia in thalassemia

Philadelphia chromosome and the role it plays in chronic myeloid leukaemia

Eltrombopag helped reduce bleeding in children with immune thrombocytopenic purpura

Pivotal ruxolitinib data shows promise for patients with PV

Personalised medicine in Europe needs to be accessible to all